This inventor holds 1 USPTO granted patent. Top assignee: Csl Behring Gmbh. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Christoph Licht: Innovator in Chronic Nephropathies Treatment
Introduction
Christoph Licht is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of chronic nephropathies. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Licht holds a patent for "Factor H for the treatment of chronic nephropathies and production thereof." This invention relates to the use of Factor H for the manufacture of a medicament aimed at treating both chronic nephropathies that are not causally associated with proteinuria and those that are. Additionally, the patent includes large-scale purification methods for Factor H, showcasing his commitment to advancing medical treatments.
Career Highlights
Christoph Licht is associated with CSL Behring GmbH, a company known for its focus on innovative therapies. His work at the company has been instrumental in developing treatments that improve patient outcomes in nephrology.
Collaborations
Licht has collaborated with notable colleagues in his field, including Peter Zipfel and Christine Skerka. These partnerships have enhanced the research and development of effective treatments for chronic kidney diseases.
Conclusion
Christoph Licht's contributions to the treatment of chronic nephropathies through his innovative patent demonstrate his dedication to improving healthcare. His work continues to impact the medical community positively.